Video

More Awareness Is Needed When Treating WTC Responders, Says Dr Anna E. Mullins

Anna E. Mullins, PhD, assistant professor at the Icahn School of Medicine at Mount Sinai, discusses the necessity of awareness of how health issues can present in World Trade Center (WTC) responders.

Raising awareness and implementing systematic tools to measure patient-focused outcomes can help those who responded to the 9/11 attacks, says Anna E. Mullins, PhD, assistant professor at the Icahn School of Medicine at Mount Sinai.

Mullins was the lead author of “Sleep Disorders and Chronic Rhinosinusitis in World Trade Center (WTC) Responders and a Sleep Clinic Population,” an abstract presented at the 2023 American Thoracic Society International Conference.

Transcript

What should providers and health care systems be doing to raise awareness on how sleep conditions have manifested in WTC responders?

WTC responders, with respect to sleep disorders, such as for instance, sleep apnea, they present a little differently in that they tend to have lower [body mass index], they present with more insomnia symptoms or more of an insomnia phenotype, and then they have other comorbidities that affect their sleep such as gastrointestinal reflux disorder and chronic rhinosinusitis.

Based on your findings, what can health professionals do to improve the diagnosis, treatment, and management of chronic rhinosinusitis and sleep quality in WTC responders?

There needs to be raised awareness of the differing presentation of sleep disorders and the comorbidities and to foster increasing integrative care amongst many disciplines. What my colleagues have said would be useful is more systematic tools to capture patient-focused outcomes so that the things that are meaningful to the responders can be focused on and integrated into their care.

Related Videos
Lalan Wilfong, MD, during a video interview
Klaus Rabe, MD, PhD, chest physician and professor of medicine, University of Kiel
dr ken cohen
Ana Baramidze, MD, PhD
Eva Otter, president of PHA Europe
Samyukta Mullangi, MD, MBA.
Alexander Mathioudakis, MD, PhD, clinical lecturer in respiratory medicine, The University of Manchester
Wanda Phipatanakul, MD, MS, professor of pediatrics, Harvard Medical School; director of the Clinical Research Center, Boston Children's Hospital
Io Hui, PhD, researcher at The University of Edinburgh
Anna-Maria Hoffmann-Vold, MD, PhD, a senior consultant and leader of inflammatory and fibrotic research area at Oslo University Hospital
Related Content
CH LogoCenter for Biosimilars Logo